Patents by Inventor Ned R. Siegel

Ned R. Siegel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090203589
    Abstract: The present invention provides a chemically modified human Growth Hormone (hGH) receptor antagonists prepared by attaching a single polyethylene glycol moiety to the N-terminus. The chemically-modified protein according to the present invention have decreased PEGylation heterogeneity and which may also have increased binding affinity.
    Type: Application
    Filed: January 31, 2005
    Publication date: August 13, 2009
    Inventors: Thomas J. Girard, Rory F. Finn, Ned R. Siegel
  • Publication number: 20090171071
    Abstract: The invention provides PYY3-36 variants and pegylated derivatives thereof and compositions and methods useful in the treatment of conditions modulated by an NPY Y2 receptor agonist.
    Type: Application
    Filed: February 26, 2009
    Publication date: July 2, 2009
    Inventors: Neena L. Summers, Rory R. Finn, Ned R. Siegel, Nancy A. Nardone
  • Publication number: 20090170778
    Abstract: The invention provides PYY3-36 variants and pegylated derivatives thereof and compositions and methods useful in the treatment of conditions modulated by an NPY Y2 receptor agonist.
    Type: Application
    Filed: February 26, 2009
    Publication date: July 2, 2009
    Inventors: Neena L. Summers, Rory R. Finn, Ned R. Siegel, Nancy A. Nardone
  • Publication number: 20030171285
    Abstract: The present invention provides a chemically modified human Growth Hormone (hGH) prepared by binding a water soluble polymer to the protein. The chemically-modified protein according to the present invention may have a much longer lasting hGH activity than that of the un-modified hGH, enabling reduced dose and scheduling opportunities.
    Type: Application
    Filed: November 20, 2002
    Publication date: September 11, 2003
    Inventors: Rory F. Finn, Wei Liao, Ned R. Siegel
  • Patent number: 6448381
    Abstract: A novel heparin-binding growth factor of 18.9 kDa mol. wt. is disclosed which is purified from bovine uterus and human placenta and has a unique 25 N-terminal amino acid sequence as follows: Gly-Lys-Lys-Glu-Lys-Pro-Glu-Lys-Lys-Val-Lys-Lys-Ser-Asp-Cys-Gly-Glu-Trp-Gln-Trp-Ser-Val-Cys-Val-Pro.
    Type: Grant
    Filed: June 21, 1990
    Date of Patent: September 10, 2002
    Assignee: Barnes-Jewish Hospital
    Inventors: Thomas F. Deuel, Yue-Sheng Li, Ned R. Siegel, Peter G. Milner
  • Patent number: 6136562
    Abstract: This invention relates to bovine placental lactogen, amino acid sequences thereof, DNA sequences coding therefor, its production by synthetic means and its use to produce a biological response in cattle.
    Type: Grant
    Filed: November 20, 1992
    Date of Patent: October 24, 2000
    Assignee: Monsanto Company
    Inventors: John C. Byatt, Scott D. Hauser, Gwen G. Krivi, Ned R. Siegel, Christine E. Smith, Jeannine M. Stafford
  • Patent number: 6130333
    Abstract: The present invention provides for compounds having the following Formulae I-III, ##STR1## and ##STR2## The compounds of the present invention are useful in the treatment of a variety of disease such as glaucoma, sexual dysfunction, asthma and cardiovascular disorders such as stable-, unstable- and variant-angina, hypertension, pulmonary hypertension, congestive heart failure, atherosclerosis, and thrombosis.
    Type: Grant
    Filed: November 27, 1998
    Date of Patent: October 10, 2000
    Assignee: Monsanto Company
    Inventors: Horng-Chih Huang, Timothy S. Chamberlain, Steven Lynn Settle, William Dean Joy, Ned R. Siegel, Leslie D. Bell
  • Patent number: 5039792
    Abstract: An eighteen amino acid neuropeptide isolated from brain complexes of adult female cockroach, Diploptera punctata, is identified as an allatostatin because it inhibits the biosynthesis of juvenile growth hormone in cockroach corpora allata. Primary structure of the isolated allatostatin is Al a-Tyr-Ser-Tyr-Val-Ser-Glu-Tyr-Lys-Arg-Leu-Pro-Val-Tyr-Asn-Phe-Gly-Leu-NH.s ub.2. A synthetic peptide of this sequence and three synthetic peptides with truncated sequences conserving the amidated carboxyl portion of the native sequence have allatostatin activity. Certain derivatives of the peptides also have allatostatin activity including compounds having the sequence: X-Val-Tyr-Asn-Phe-Gly-Leu-NH.sub.2, in which X is Leu-Arg, Leu-Pro, Arg-Leu-Pro-, Ala-Tyr-Ser-Tyr-Val-Ser-Glu-Tyr-Lys-Arg-Leu-Pro, acetyl-Ala-Tyr-Ser-Tyr-Val-Ser-Glu-Tyr-Lys-Arg-Leu-Pro, or acetyl-Arg-Leu-Pro. These peptides have the potential for regulating the growth of certain insects, and may be useful in the area of insect control.
    Type: Grant
    Filed: December 18, 1989
    Date of Patent: August 13, 1991
    Assignees: Oregon State University, Monsanto Company
    Inventors: Rene Feyereisen, Grahame E. Pratt, Dan E. Farnsworth, Ned R. Siegel, Kam F. Fok
  • Patent number: 4981956
    Abstract: This invention relates to novel peptides having utility for promotion of growth and/or lactation in animals, to processes and DNA useful in production of such peptides, and to methods utilizing such peptides to promote growth or lactation in animals. In some embodiments, the invention is directed to peptides having bovine IGF-II biological activity, to production of such peptides, and to their use in effecting proliferation of certain cells (e.g. mammary epithelial or muscle) or in enhancing lactation in cattle or other animals.
    Type: Grant
    Filed: October 6, 1988
    Date of Patent: January 1, 1991
    Assignee: Monsanto Company
    Inventors: Brent R. Larsen, Ned R. Siegel, Claire E. Kotts, Michael F. McGrath, Sharon D. Ogden, Gwen G. Krivi, John C. Minnerly
  • Patent number: 4783524
    Abstract: This invention relates to novel peptides having utility for promotion of growth and/or lactation in animals, to processes and DNA useful in production of such peptides, and to methods utilizing such peptides to promote growth or lactation in animals. In some embodiments, the invention is directed to peptides having bovine IGF-II biological activity, to production of such peptides, and to their use in effecting proliferation of certain cells (e.g. mammary epithelial or muscle) or in enhancing lactation in cattle or other animals.
    Type: Grant
    Filed: July 31, 1986
    Date of Patent: November 8, 1988
    Assignee: Monsanto Company
    Inventors: Brent R. Larsen, Ned R. Siegel, Claire E. Kotts, Michael F. McGrath, Sharon D. Ogden, Gwen G. Krivi, John C. Minnerly